Cargando…

Molecular Markers Guiding Thyroid Cancer Management

The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical models, high throughput molecular technologies, and gene expression microarrays have provided a deeper understandin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nylén, Carolina, Mechera, Robert, Maréchal-Ross, Isabella, Tsang, Venessa, Chou, Angela, Gill, Anthony J., Clifton-Bligh, Roderick J., Robinson, Bruce G., Sywak, Mark S., Sidhu, Stan B., Glover, Anthony R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466065/ https://www.ncbi.nlm.nih.gov/pubmed/32759760 http://dx.doi.org/10.3390/cancers12082164

Ejemplares similares

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma
por: Kesby, Nicholas, et al.
Publicado: (2023)

Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update
por: Worrall, Benjamin J, et al.
Publicado: (2023)

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
por: Fuchs, Talia L., et al.
Publicado: (2020)

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
por: Tsang, Venessa, et al.
Publicado: (2022)

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas
por: Bullock, Martyn, et al.
Publicado: (2016)

Immune Related Adverse Events of the Thyroid – A Narrative Review
por: Muir, Christopher A., et al.
Publicado: (2022)

Unexpected deaths after endocrine surgery: learning from rare events using a national audit of surgical mortality
por: Chui, Juanita N, et al.
Publicado: (2022)

Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors
por: Muir, Christopher Alan, et al.
Publicado: (2021)

A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
por: Chou, Angela, et al.
Publicado: (2015)

Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil
por: Lin, Mike, et al.
Publicado: (2020)

Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer
por: White, Eleanor, et al.
Publicado: (2023)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Sonographic Volumetric Assessment Is a More Accurate Measure Than Maximum Diameter Alone in Papillary Thyroid Cancer
por: Pennington, Thomas E, et al.
Publicado: (2018)

15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
por: Benn, Diana E, et al.
Publicado: (2015)

Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas
por: Gill, Anthony J., et al.
Publicado: (2014)

Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy
por: Martínez-Aguilar, Juan, et al.
Publicado: (2016)

Tumour volume is a predictor of lymphovascular invasion in differentiated small thyroid cancer
por: Vikneson, Krishna, et al.
Publicado: (2022)

Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
por: Gild, Matti L, et al.
Publicado: (2022)

A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours
por: Martínez-Aguilar, Juan, et al.
Publicado: (2015)

The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
por: Clifton-Bligh, Roderick J.
Publicado: (2023)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
por: Wu, Linda, et al.
Publicado: (2021)

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
por: Tsang, Venessa H M, et al.
Publicado: (2020)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

ACTH-secreting medullary thyroid cancer: a case series
por: Wijewardene, Ayanthi A, et al.
Publicado: (2017)

Risk of needing completion thyroidectomy for low‐risk papillary thyroid cancers treated by lobectomy
por: DiMarco, A. N., et al.
Publicado: (2019)

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
por: Gill, Anthony J., et al.
Publicado: (2019)

Thyroid Hormone Abuse Among Elite Athletes
por: Handelsman, David J, et al.
Publicado: (2023)

Destabilizing RET in targeted treatment of thyroid cancers
por: Gild, M L, et al.
Publicado: (2015)

Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma
por: Dwight, Trisha, et al.
Publicado: (2017)

Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT
por: Bullock, Martyn, et al.
Publicado: (2016)

Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia
por: Kaplan, Adam I, et al.
Publicado: (2022)

Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types()
por: Kim, Edward, et al.
Publicado: (2016)

Foxe1 Deletion in the Adult Mouse Is Associated With Increased Thyroidal Mast Cells and Hypothyroidism
por: Lim, Grace, et al.
Publicado: (2022)

Current management options for recurrent adrenocortical carcinoma
por: Glover, Anthony R, et al.
Publicado: (2013)

Key MicroRNA’s and Their Targetome in Adrenocortical Cancer
por: Chehade, Marthe, et al.
Publicado: (2020)

Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing
por: Cole, Alexander J., et al.
Publicado: (2016)

Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency
por: Cole, Alexander J., et al.
Publicado: (2017)

RF11 | PSAT370 I-PET Score: Combining Whole Body Iodine Scan and 18 Fluorodeoxyglucose Positron Emission Topography to Predict Progression in Thyroid Cancer
por: Wijewardene, Ayanthi, et al.
Publicado: (2022)

Clinical Activity of Selpercatinib in RET Mutant Pheochromocytoma-Case Reports
por: Konda, Bhavana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_msp1i3ucjv8kpofamedkdngidn